tiprankstipranks
Trending News
More News >
Rohto Pharmaceutical Co (JP:4527)
:4527
Japanese Market

Rohto Pharmaceutical Co (4527) Income Statement

Compare
1 Followers

Rohto Pharmaceutical Co Income Statement

Last quarter (Q1 2026), Rohto Pharmaceutical Co's total revenue was ¥81.96B, an increase of 19.91% from the same quarter last year. In Q1, Rohto Pharmaceutical Co's net income was ¥11.77B. See Rohto Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 308.63B¥ 270.84B¥ 238.66B¥ 199.65B¥ 181.05B
Gross Profit
¥ 169.38B¥ 157.29B¥ 137.42B¥ 116.49B¥ 106.73B
Operating Expenses
¥ 130.92B¥ 117.24B¥ 103.46B¥ 87.14B¥ 83.73B
Depreciation and Amortization
¥ 13.14B¥ 8.69B¥ 7.80B¥ 7.69B¥ 6.75B
EBITDA
¥ 56.42B¥ 50.40B¥ 42.34B¥ 35.81B¥ 28.61B
Operating Income
¥ 38.47B¥ 40.05B¥ 33.96B¥ 29.35B¥ 22.99B
Other Income/Expenses
¥ 3.39B¥ 1.47B¥ 331.00M¥ -1.40B¥ 16.00M
Pretax Income
¥ 42.33B¥ 41.52B¥ 34.29B¥ 27.95B¥ 23.01B
Net Income
¥ 31.00B¥ 30.94B¥ 26.38B¥ 21.13B¥ 16.74B
Per Share Metrics
Basic EPS
¥ 136.11¥ 135.60¥ 115.62¥ 92.61¥ 73.39
Diluted EPS
¥ 135.46¥ 135.21¥ 115.29¥ 92.34¥ 73.18
Weighted Average Shares Outstanding
227.80M 228.14M 228.14M 228.14M 228.14M
Weighted Average Shares Outstanding (Diluted)
228.90M 228.80M 228.80M 228.80M 228.80M
Currency in JPY

Rohto Pharmaceutical Co Earnings and Revenue History